E. Juszczak

University of Oxford

Health Outcomes Studied

• Reduced Colitis-Related Mortality

Papers (2)

• 2016
  Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial10.1016/S0140-6736(15)01027-2
• 2016
  A randomised controlled trial of the probiotic Bifidobacterium breve BBG-001 in preterm babies to prevent sepsis, necrotising enterocolitis and death: the Probiotics in Preterm infantS (PiPS) trial.10.3310/hta20660